What is the first‑line antibiotic regimen for uncomplicated typhoid fever in adults, considering local susceptibility patterns and special populations such as pregnancy and β‑lactam allergy?

Medicine Used for Typhoid Fever

Azithromycin 500 mg once daily for 7-14 days is the first-line antibiotic for uncomplicated typhoid fever in adults, particularly given widespread fluoroquinolone resistance exceeding 70% in endemic regions. 1, 2

First-Line Treatment Regimen

Azithromycin is the preferred empiric therapy for typhoid fever:

• Adults: 500 mg orally once daily for 7-14 days 1, 2
• Children: 20 mg/kg/day (maximum 1 g/day) orally for 7-14 days 1, 2
• Pregnancy: Azithromycin is FDA Pregnancy Category B and safe to use 2

This recommendation is based on superior clinical outcomes compared to alternatives, with 52% lower clinical failure rates (OR 0.48) versus fluoroquinolones and dramatically lower relapse rates (OR 0.09) compared to ceftriaxone. 1, 2, 3

Why Azithromycin Over Other Antibiotics

Geographic Resistance Patterns Drive This Choice

• Fluoroquinolone resistance exceeds 70% in South and Southeast Asia, with some regions approaching 96% resistance 1, 2
• Never use ciprofloxacin empirically for cases originating from South/Southeast Asia due to near-universal resistance 1, 2
• Fluoroquinolones should only be considered when culture confirms nalidixic acid susceptibility AND the case is not from Asia 2

Clinical Superiority of Azithromycin

• Hospital stays are 1 day shorter with azithromycin versus fluoroquinolones (mean difference -1.04 days) 1, 3
• Relapse risk is 91% lower with azithromycin versus ceftriaxone (OR 0.09) 1, 2, 3
• Fever clearance occurs in 5.8 days on average with azithromycin 2, 4
• Azithromycin retains activity against multidrug-resistant strains (resistant to chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole) 2, 5

Alternative Treatment Options

When Azithromycin Cannot Be Used

Ceftriaxone (intravenous/intramuscular):

• Adults: 1-2 g IV/IM daily for 5-7 days 2
• Children: 50-80 mg/kg/day (maximum 2 g/day) IV/IM for 5-7 days 2
• All S. Typhi isolates remain susceptible to ceftriaxone 1
• Reduces treatment failure risk compared to gatifloxacin (hazard ratio 0.24) 2

Fluoroquinolones (ciprofloxacin):

• Only when susceptibility is confirmed by culture showing nalidixic acid sensitivity 1, 2
• Adults: 500 mg orally twice daily for 10 days 6
• Achieves fever clearance in <4 days with >96% cure rates when organism is susceptible 1
• Contraindicated in pregnancy 2

Critical Pitfall: Avoid Cefixime

Cefixime has unacceptably high failure rates:

• Treatment failure rates of 4-37.6% reported 1, 2
• 13-fold higher risk of clinical failure versus fluoroquinolones (RR 13.4) 1
• WHO lists cefixime only as "alternative" agent, not first-line 2
• If cefixime must be used, mandatory test-of-cure at 1 week is required 1

Treatment Algorithm Based on Clinical Presentation

Step 1: Obtain Blood Cultures Before Starting Antibiotics

• Blood cultures have highest yield (40-80% sensitivity) within first week of symptoms 1, 2
• In patients with sepsis features, start broad-spectrum therapy immediately after drawing cultures 7, 2

Step 2: Start Empiric Azithromycin

• Begin azithromycin 500 mg once daily orally 1, 2
• Do not wait for culture results in stable patients 1

Step 3: Monitor Clinical Response

• Expect fever clearance within 4-5 days of appropriate therapy 1, 2, 8
• If no improvement by day 5, consider resistance or alternative diagnosis 8

Step 4: Complete Full Course

• Never discontinue antibiotics prematurely even if fever resolves early 1, 8
• Complete full 7-14 day course to prevent relapse (occurs in 10-15% if inadequately treated) 1, 8

Special Populations

β-Lactam Allergy

• Azithromycin is the preferred alternative (not a β-lactam) 1, 2
• Fluoroquinolones may be considered only if susceptibility is confirmed 1

Pregnancy

• Azithromycin is safe (FDA Pregnancy Category B) 2
• Fluoroquinolones are contraindicated in pregnancy 2
• Ceftriaxone is also safe if parenteral therapy is needed 2

Monitoring and Expected Outcomes

Clinical Response Timeline

• Fever should clear within 4-5 days of starting azithromycin 1, 2, 8
• Mean fever clearance time is 5.8 days (95% CI 5.1-6.5 days) 2, 4
• If fever persists beyond 5 days, switch therapy or reassess diagnosis 8

Common Adverse Effects of Azithromycin

• Mild gastrointestinal symptoms: nausea, vomiting, abdominal pain, diarrhea 1, 2
• Monitor for QT-prolonging drug interactions 1, 2
• Generally well tolerated with few serious adverse events 5, 4

Management of Treatment Failure

When to Switch from Initial Therapy

If ceftriaxone fails (no fever clearance by day 5):

• Switch immediately to azithromycin 500 mg once daily for 7-14 days 8
• Obtain repeat blood cultures before switching 8

If azithromycin fails:

• Consider ceftriaxone 1-2 g IV/IM daily 2, 8
• Reassess diagnosis for alternative causes 8

Complications Requiring Surgical Intervention

Intestinal Perforation

• Occurs in 10-15% of patients when illness duration exceeds 2 weeks 1, 2
• Requires immediate surgical intervention 1
• Simple excision and closure achieves 88% success rate 1, 2
• Primary repair recommended for single perforation with minimal contamination 2
• Resection with anastomosis advised for multiple perforations or unhealthy bowel 2

Prevention Strategies

Typhoid Vaccination

• Recommended for travelers to endemic areas (Latin America, Asia, Africa) 1, 2
• Ty21a oral vaccine: One capsule on alternate days for total of 4 capsules; booster every 5 years 2
• Vi-polysaccharide parenteral vaccine: 0.5 mL subcutaneously in 2 doses ≥4 weeks apart; booster every 3 years 2
• Provides only 50-80% protection and does not protect against Salmonella Paratyphi 1, 2
• Do not use combination typhoid-paratyphoid vaccines - only monovalent S. Typhi preparations recommended 2

Essential Precautions

• Hand hygiene and food/water safety remain essential and cannot be replaced by vaccination alone 1, 2